Probenecid arrests the progression of pronounced clinical symptoms in a mouse model of multiple sclerosis
暂无分享,去创建一个
S. Wagenpfeil | C. Meier | T. Tschernig | N. Hainz | S. Wolf | A. Beck
[1] C. Beisswenger,et al. Probenecid-treatment reduces demyelination induced by cuprizone feeding , 2017, Journal of Chemical Neuroanatomy.
[2] Michael Mousseau,et al. Blocking microglial pannexin-1 channels alleviates morphine withdrawal in rodents , 2017, Nature Medicine.
[3] C. Maack,et al. Brain damage resulting from postnatal hypoxic-ischemic brain injury is reduced in C57BL/6J mice as compared to C57BL/6N mice , 2016, Brain Research.
[4] X. Xiong,et al. Probenecid protects against oxygen–glucose deprivation injury in primary astrocytes by regulating inflammasome activity , 2016, Brain Research.
[5] E. Scemes,et al. Pannexin1 Channels Are Required for Chemokine-Mediated Migration of CD4+ T Lymphocytes: Role in Inflammation and Experimental Autoimmune Encephalomyelitis , 2016, The Journal of Immunology.
[6] C. Meier,et al. Probenecid Application Prevents Clinical Symptoms and Inflammation in Experimental Autoimmune Encephalomyelitis , 2016, Inflammation.
[7] B. Luo,et al. Probenecid protects against cerebral ischemia/reperfusion injury by inhibiting lysosomal and inflammatory damage in rats , 2015, Neuroscience.
[8] K. Stokes,et al. Pannexin 1 channels regulate leukocyte emigration through the venous endothelium during acute inflammation , 2015, Nature Communications.
[9] D. Volmer,et al. Differential distribution of probenecid as detected by on-tissue mass spectrometry , 2015, Cell and Tissue Research.
[10] D. Volmer,et al. Differential distribution of probenecid as detected by on-tissue mass spectrometry , 2015, Cell and Tissue Research.
[11] K. Schroder,et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases , 2015, Nature Medicine.
[12] N. Leitinger,et al. The role of pannexin1 in the induction and resolution of inflammation , 2014, FEBS letters.
[13] I. Jalilian,et al. Probenecid Blocks Human P2X7 Receptor-Induced Dye Uptake via a Pannexin-1 Independent Mechanism , 2014, PloS one.
[14] Sunhee C. Lee,et al. Contribution of Pannexin1 to Experimental Autoimmune Encephalomyelitis , 2013, PloS one.
[15] Young-Joo Lee,et al. Low‐dose probenecid selectively inhibits urinary excretion of phenolsulfonphthalein in rats without affecting biliary excretion , 2013, Journal of applied toxicology : JAT.
[16] D. Yellon,et al. Novel treatment strategies , 2012 .
[17] Frauke Zipp,et al. Neurodegeneration in multiple sclerosis: novel treatment strategies , 2012, Expert review of neurotherapeutics.
[18] David Baker,et al. In vitro and in vivo models of multiple sclerosis. , 2012, CNS & neurological disorders drug targets.
[19] Donna Graves,et al. Current and emerging therapies in multiple sclerosis: a systematic review , 2012, Therapeutic advances in neurological disorders.
[20] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[21] Jeffrey A. Cohen,et al. Multiple sclerosis: new insights in pathogenesis and novel therapeutics. , 2012, Annual review of medicine.
[22] L. Hua,et al. The Gap-junction inhibitor Carbenoxolone suppresses the differentiation of Th17 cells through inhibition of IL-23 expression in antigen presenting cells , 2011, Journal of Neuroimmunology.
[23] Michael R. Elliott,et al. Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis , 2010, Nature.
[24] J. P. de Rivero Vaccari,et al. The Pannexin 1 Channel Activates the Inflammasome in Neurons and Astrocytes* , 2009, The Journal of Biological Chemistry.
[25] A. Suzumura,et al. Blockade of glutamate release from microglia attenuates experimental autoimmune encephalomyelitis in mice. , 2009, The Tohoku journal of experimental medicine.
[26] J. Buer,et al. Purinergic Control of T Cell Activation by ATP Released Through Pannexin-1 Hemichannels , 2008, Science Signaling.
[27] G. Dahl,et al. Probenecid, a gout remedy, inhibits pannexin 1 channels. , 2008, American journal of physiology. Cell physiology.
[28] Amaia M. Arranz,et al. P2X7 Receptor Blockade Prevents ATP Excitotoxicity in Oligodendrocytes and Ameliorates Experimental Autoimmune Encephalomyelitis , 2007, The Journal of Neuroscience.
[29] W. Gan,et al. ATP mediates rapid microglial response to local brain injury in vivo , 2005, Nature Neuroscience.
[30] G. Dahl,et al. Pannexin membrane channels are mechanosensitive conduits for ATP , 2004, FEBS letters.
[31] Catherine L Nutt,et al. The Oligodendroglial Lineage Marker OLIG2 Is Universally Expressed in Diffuse Gliomas , 2004, Journal of neuropathology and experimental neurology.
[32] Amaia M. Arranz,et al. P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.